imatinib mesylate has been researched along with Endometrioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akkar, OB; Cetin, A; Kacan, SB; Kacan, T; Karakus, S; Ozer, H; Seker, M; Yildiz, C | 1 |
| Jensen, JR; Schenken, RS; Tekmal, RR; Witz, CA | 1 |
2 other study(ies) available for imatinib mesylate and Endometrioma
| Article | Year |
|---|---|
Effect of imatinib on growth of experimental endometriosis in rats.
Topics: Anastrozole; Angiogenesis Inhibitors; Animals; Aromatase Inhibitors; bcl-2-Associated X Protein; Cell Proliferation; Disease Models, Animal; Endometriosis; Endometrium; Female; Imatinib Mesylate; Nitriles; Ovarian Follicle; Peritoneal Diseases; Peritoneum; Proto-Oncogene Proteins c-kit; Rats; Transplantation, Autologous; Triazoles; Vascular Endothelial Growth Factor A | 2016 |
A potential role for colony-stimulating factor 1 in the genesis of the early endometriotic lesion.
Topics: Animals; Benzamides; Cell Proliferation; Disease Models, Animal; Endometriosis; Endometrium; Estradiol; Female; Homozygote; Imatinib Mesylate; Macrophage Colony-Stimulating Factor; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mutation; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptor, Macrophage Colony-Stimulating Factor; Time Factors | 2010 |